abstract |
Compounds of formula (I): **(See formula)** or of formula (II) **(See formula)** in which R1 and R2, the same or different, are H or CH3 for use in prevention and treatment of chronic low-grade systemic inflammation (CLGSI) associated with chronic low-grade systemic inflammation (CLGSI)-related diseases selected from the group consisting of: chronic inflammatory diseases, autoimmune diseases, chronic degenerative diseases, related tumors with chronic low-grade systemic inflammation (CLGSI), obesity, diabetes, arterial hypertension, osteoporosis, diseases of the respiratory system and polycystic ovary syndrome, where the compounds of formula (I) and (II) reduce chronic low-grade systemic inflammation grade. |